The prevention of coronary heart disease (CHD) has never been more important. Throughout the world death rates from cardiovascular causes are rising and are soon estimated to overtake infectious diseases as the leading global cause of death for the first time in history. All healthcare professionals need to understand what causes this disease and how to prevent it. This new edition of this highly successful book brings together the latest information and research on CHD; in particular, the health professional's role in prevention of the disease. It gives practical advice on correcting these factors through lifestyle and medical management. Updates for the second edition include:coverage of the new large lipid-lowering drug trials therapeutic advances in the use of thrombolytic, antiplatelet and anti-hypertensive drugs advances in treatments including diabetic control, anti-smoking therapy, prescription of exercise and the use of dietary advice. This book is aimed at the broad range of professionals who come into contact with CHD patients and with those at risk of CHD, including nurses, physiotherapists, dieticiansdietitians, occupational therapists, clinical psychologists, general practitioners, doctors who are involved in prevention and rehabilitation and all staff working in coronary care units, lipid and hypertension clinics and general cardiology clinics. evidence-based content ensures a firm scientific basis for practice the practical nature of the content can be immediately applied in the working environment e.g. smoking cessation strategies, dietary counseling and risk assessment the multidisciplinary group of contributors ensures that the content reflects the multidisciplinary nature of CHD prevention work case studies and practice exercises enable the application of theory to practice summaries of key points facilitate understanding and retention the implications from clinical governance legislation, the National Service Frameworks and Joint British Recommendations on prevention of CHD in clinical practice recent research outcomes e.g. the HOT trial diabetes and its links with CHD material relating to ethnic minorities more 'global' statistics where possible to make the text more appealing to international markets the inequalities arising from socio-economic exclusion

Reflecting new discoveries in fingerprint science, Lee and Gaensslen's Advances in Fingerprint Technology, Third Edition has been completely updated with new material and nearly double the references contained in the previous edition. The book begins with a detailed review of current, widely used development techniques, as well as some older, historical methods. Next, it describes more recent advances as well as novel, emerging technologies that have just begun to reach maturity. Highlights in this edition include: Comprehensive details about work performed by the UK Home Office on the use of powders and brushes Advances in the area of blood reagents, and the transition from previously carcinogenic peroxidase reagents to new and safer protein staining methods The vacuum metal deposition technique The cyanoacrylate fuming process An update on ninhydrin analogs Emerging trends in print development using nanotechnology Latent print recovery and decontamination at scenes tainted by chemical, biological, radiological, nuclear, and explosive materials A model for quantitatively interpreting and assessing minutiae in a print Methods for digital and chemical imaging of latent prints With contributions by a renowned group of leading forensic scientists and criminalistics experts, this valuable work presents the latest progress in fingerprint technologies, comparison, and identification.

Contents:
1. Hyperlipidaemia as a Risk Factor for Coronary Heart Disease 2. Lipid Control in the Pre-Statin Era 3. The Discovery and Development of the Statins 4. Comparative Chemistry, Pharmacology and the Mechanism of Action of the Statins 5. Ancillary Benefits of the Statins 6. Angiographic and IVUS Techniques Evaluating Progression and Regression of Coronary Atherosclerosis: Statin Intervention Trials in Perspective 7. The Scandanavian Simvastatin Survival Study (4S) 8. Primary Prevention of Coronary Heart Disease with Statins 9. The CARE (Cholesterol and Recurrent Events) Trial: The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels 10. The LIPID (Long-term Intervention with Pravastatin in Ischemic Disease) Study: Results and Implications for Clinical Practice 11. Mega-trials: the Prospective Pravastatin Pooling Project (PPP) and the Heart Protection Study (HPS) 12. The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) 13. Combination Therapy with Statins 14. Guidelines for Clinical Use of the Statins 15. The Cost-effectiveness of Statin Use 16. Unanswered Questions About the Use of Statins 17. Statin Therapy for the 21st Century

Contents:
1. Why Do We Use Satins? 2. How Do We Assess Dyslipidaemia? 3. What Are the Statins and How Do They Work? 4. Who Should Receive Statin Therapy? 5. What About Statin Use in the Elderly? 6. What Does the Future Hold? 7. Glossary of Terms

Reflecting new discoveries in fingerprint science, Lee and Gaensslen s Advances in Fingerprint Technology, Third Edition has been completely updated with new material and nearly double the references contained in the previous edition. The book begins with a detailed review of current, widely used development techniques, as well as some older, historical methods. Next, it describes more recent advances as well as novel, emerging technologies that have just begun to reach maturity.

Highlights in this edition include:

• Comprehensive details about work performed by the UK Home Office on the use of powders and brushes
• Advances in the area of blood reagents, and the transition from previously carcinogenic peroxidase reagents to new and safer protein staining methods
• The vacuum metal deposition technique
• The cyanoacrylate fuming process
• An update on ninhydrin analogs
• Emerging trends in print development using nanotechnology
• Latent print recovery and decontamination at scenes tainted by chemical, biological, radiological, nuclear, and explosive materials
• A model for quantitatively interpreting and assessing minutiae in a print
• Methods for digital and chemical imaging of latent prints

With contributions by a renowned group of leading forensic scientists and criminalistics experts, this valuable work presents the latest progress in fingerprint technologies, comparison, and identification.

This new edition of "Clinical Biochemistry" covers all aspects of the subject needed by medical students. It is a volume in the "Illustrated Colour Text" series, with the subject matter divided into double-page spreads; this makes the information very accessible to the reader. Full use is made of Flow charts and other graphics; clinical boxes; summary points; case histories; and clinical photographs. The whole orientation of this book is to concentrate on how clinical biochemistry relates to the care of the patient and to ensure that the medical student understands how to interpret laboratory results. By contrast, the reader is not overburdened by descriptions of laboratory techniques.